GT Biopharma's total assets for Q2 2025 were $7.12M, an increase of 168.02% from the previous quarter. GTBP total liabilities were $2.31M for the fiscal quarter, a -36.59% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.